Atlas Trials

Randomized Trial of Adult Participants With Generalized Anxiety Disorder

Clinical trial NCT03829241 · COMPLETED

Trial details

NCT number
NCT03829241
Sponsor
Biohaven Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Generalized Anxiety Disorder
Start date
2019-02-19
Primary completion
2020-01-14
Enrollment
881

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.